Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04262167
What this trial is testing

Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease
University of North Carolina, Chapel Hill 24
Testing effectiveness (Phase 2)Ended earlyNCT00690885
What this trial is testing

Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Disease, Chronic ObstructivePulmonary FibrosisCough
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 1
Early research (Phase 1)Study completedNCT05657184
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001

Who this might be right for
Idiopathic Pulmonary Fibrosis
Regend Therapeutics 12
Not applicableLooking for participantsNCT07373288
What this trial is testing

HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis

Who this might be right for
Fibrosis, Pulmonary
University of Modena and Reggio Emilia 80
Testing effectiveness (Phase 2)Looking for participantsNCT07230288
What this trial is testing

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
AbbVie 165
Not applicableLooking for participantsNCT03437486
What this trial is testing

Mechanisms of Familial Pulmonary Fibrosis

Who this might be right for
Familial Pulmonary FibrosisIdiopathic Pulmonary FibrosisFamilial Interstitial Pneumonia
Vanderbilt University Medical Center 750
Early research (Phase 1)Study completedNCT03650075
What this trial is testing

To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Metagone Biotech Inc. 81
Large-scale testing (Phase 3)Study completedNCT04300920
What this trial is testing

Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

Who this might be right for
Idiopathic Pulmonary Fibrosis
Fernando J Martinez 202
Early research (Phase 1)Study completedNCT06502379
What this trial is testing

A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 147
Testing effectiveness (Phase 2)Study completedNCT00352482
What this trial is testing

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisHypertension, Pulmonary
National Heart, Lung, and Blood Institute (NHLBI) 20
Not applicableStudy completedNCT04316780
What this trial is testing

Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes

Who this might be right for
Idiopathic Pulmonary Fibrosis
Steward St. Elizabeth's Medical Center of Boston, Inc. 320
Early research (Phase 1)Study completedNCT05932303
What this trial is testing

Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 47
Testing effectiveness (Phase 2)Study completedNCT04312594
What this trial is testing

Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 91
Not applicableStudy completedNCT03641742
What this trial is testing

Families-At-risk for Interstitial Lung Disease Study

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Columbia University 125
Large-scale testing (Phase 3)Ended earlyNCT02759120
What this trial is testing

CleanUP IPF for the Pulmonary Trials Cooperative

Who this might be right for
Idiopathic Pulmonary Fibrosis
Weill Medical College of Cornell University 513
Large-scale testing (Phase 3)Study completedNCT02460588
What this trial is testing

Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)Study completedNCT01529853
What this trial is testing

To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sanofi 24
Not applicableLooking for participantsNCT01915511
What this trial is testing

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Who this might be right for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Duke University 3,000
Not applicableStudy completedNCT02607722
What this trial is testing

All-Case Surveillance of Ofev in Patients With IPF in Japan

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 10,117
Early research (Phase 1)Study completedNCT05154240
What this trial is testing

A Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
InSilico Medicine Hong Kong Limited 78
Next Page